NGT HealthCare II (“NGT”) is an early-stage medical device and life sciences venture capital fund, investing in promising technologies.
NGT enjoys a very significant risk reduction mechanism, by means of high non-dilutive leverage via Israel’s Innovation Authority (“IIA”). Close relationships with many of Israel’s leading universities, hospitals, and research institutions provide NGT with a rich flow of investment opportunities and a wide network of multinational corporations that further enables NGT to create value for its portfolio companies. NGT is structured as an impact fund, located in Nazareth, aligned with 3 UN SDGs.
NGT focuses on a “triple” bottom line by:
One of NGT’s social agenda goals is to develop and improve the economic potential, and by extension the socioeconomic situation of Arabs citizens of Israel, by providing the infrastructure for launching and funding early-stage life sciences and medical device companies.
NGT’s impact investment model includes working together with entrepreneurs and scientists from both the Arab and Jewish societies, and from the Israeli and international business communities.
Location: Israel, North District, Nazareth